Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMWH vs UFH in Pregnant Women with APS
NCT01051778Phase 2Completed
- Sponsor
- Cairo University
- Start
- Jun 2006
- Primary completion
- Nov 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of enoxaparin in antiphospholipid syndrome (APS) (2 arms), sponsored by Cairo University. Primary endpoint: Live Birth Rate. Started Jun 2006; status: completed.
02
Drugs
enoxaparin
03
Conditions
antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on NCT01051778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01051778.